نتائج البحث 121-130 من 12255 لعملية البحث عن Assay
Circulating Tumor DNA (cTDNA) Based in NGS (Next Generation Sequencing) Assays for Oncology Patients With Solid Tumors ... assays and results from a ctDNA assay ...
A Study to Evaluate the Safety of the Goldilocks Procedure with Implant-Based Reconstruction · CfDNA Assay Prospective Observational Validation For Early Cancer ...
CfDNA Assay Prospective Observational Validation For Early Cancer Detection And Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...
... assays to those obtained by orthogonal methods, including tissue-based assays and results from a ctDNA assay by Guardant on blood. Global Cardio Oncology ...
Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...
... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...
The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.